Mumbai A division bench of the Delhi High Court on Wednesday ordered Dr Reddy's Labs to file its reply to the injunction petition moved by Danish drug maker Novo Nordisk for its blockbuster weight-loss drug semaglutide, which is sold under the brand name Wegovy.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
An expert in intellectual property laws told ET that the order may require Dr Reddy's Labs to explain the grounds for exports of weight-loss drug semaglutide.
The court's directive comes on the back of a plea by Novo Nordisk, which alleged patent infringement. The patent for the weight-loss drug is slated to end in March next year.
You may also like
Bihar: Nitish Kumar announces hike in monthly pension for journalists to Rs 15,000; widows to get Rs 10k
Cambodia-Thailand conflict: Indian embassy in Cambodia issues advisory for nationals; shares helpline numbers
Pensions expert makes case for early access to state pension at 63
SBI Card to Discontinue Free Air Accident Insurance on Select Co-Branded Cards from August 11
Hariyali Teej 2025: Many auspicious times are being created for worship on Hariyali Teej, know about them..
